Menggang Yu Selected Research

Neutropenia

12/2012	Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial.
2/2008	A phase I and pharmacokinetic trial of erlotinib in combination with weekly docetaxel in patients with taxane-naive malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Menggang Yu Research Topics

Disease

45	Neoplasms (Cancer) 03/2024 - 08/2002
10	Breast Neoplasms (Breast Cancer) 01/2018 - 07/2009
8	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 08/2002
7	Neoplasm Metastasis (Metastasis) 11/2023 - 01/2014
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 04/2008
4	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 06/2009
4	Carcinoma (Carcinomatosis) 01/2022 - 06/2013
4	Disease Progression 01/2020 - 02/2005
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 06/2013
3	Carcinogenesis 01/2019 - 03/2010
3	Esophageal Neoplasms (Esophageal Cancer) 01/2019 - 11/2013
3	Inflammation (Inflammations) 01/2018 - 03/2010
3	Hypersensitivity (Allergy) 07/2012 - 05/2005
2	Diarrhea 01/2024 - 02/2008
2	Squamous Cell Carcinoma of Head and Neck 10/2023 - 11/2017
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023 - 11/2013
2	Adenocarcinoma 11/2022 - 11/2016
2	Circulating Neoplastic Cells 11/2022 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 12/2018 - 01/2012
2	Exanthema (Rash) 10/2013 - 01/2012
2	Thromboembolism 12/2012 - 12/2012
2	Neurofibromatosis 1 (Neurofibromatosis Type I) 12/2012 - 06/2009
2	Neutropenia 12/2012 - 02/2008
2	Juvenile Myelomonocytic Leukemia 07/2012 - 05/2005
2	Hot Flashes 05/2012 - 07/2009
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2010 - 01/2009
1	Thrombosis (Thrombus) 02/2024
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2024
1	Hepatitis 01/2024
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2023
1	Ulcer 01/2023
1	Mouth Neoplasms (Oral Cancer) 01/2023
1	COVID-19 01/2023
1	Communicable Diseases (Infectious Diseases) 01/2023

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2012
7	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 12/2012
5	Gemcitabine FDA Link 01/2024 - 10/2011
4	RNA (Ribonucleic Acid)IBA 03/2024 - 10/2022
4	coactivator-associated arginine methyltransferase 1IBA 11/2016 - 01/2014
3	pembrolizumabIBA 02/2024 - 01/2020
3	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2018
3	Transaminases (Aminotransferases)IBA 01/2024 - 01/2012
3	AndrogensIBA 11/2021 - 11/2016
3	Protein Isoforms (Isoforms)IBA 01/2015 - 07/2013
3	Cetuximab (Erbitux)FDA Link 11/2013 - 11/2009
3	Sorafenib (BAY 43-9006)FDA Link 10/2013 - 06/2009
3	Bevacizumab (Avastin)FDA Link 10/2013 - 12/2010
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2013 - 02/2008
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 07/2012 - 05/2005
3	Docetaxel (Taxotere)FDA Link 01/2012 - 02/2008
2	NivolumabIBA 01/2024 - 11/2023
2	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2013
2	Estrogen ReceptorsIBA 01/2023 - 09/2018
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2023 - 09/2018
2	Androgen Receptors (Androgen Receptor)IBA 11/2022 - 12/2017
2	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 11/2021
2	thiamine triphosphorate (TTP)IBA 04/2022 - 11/2009
2	Phenobarbital (Luminal)FDA Link 11/2021 - 12/2017
2	AntibodiesIBA 12/2018 - 01/2015
2	ErbB Receptors (EGF Receptor)IBA 12/2018 - 04/2008
2	CollagenIBA 01/2018 - 01/2017
2	Prostate-Specific Antigen (Semenogelase)IBA 11/2016 - 02/2005
2	Transcription Factors (Transcription Factor)IBA 01/2015 - 01/2014
2	Sunitinib (Sutent)FDA Link 06/2013 - 11/2012
2	Tryptophan (L-Tryptophan)FDA Link 01/2012 - 07/2009
2	Serotonin (5 Hydroxytryptamine)IBA 01/2012 - 07/2009
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2010 - 08/2010
2	NF-kappa B (NF-kB)IBA 03/2010 - 06/2009
2	taxaneIBA 12/2009 - 02/2008
2	Pemetrexed (MTA)FDA Link 11/2009 - 01/2009
1	Radium-223IBA 04/2024
1	Complement System Proteins (Complement)IBA 03/2024
1	Yttrium-90IBA 02/2024
1	Cytotoxins (Cytolysins)IBA 01/2024
1	B7-H1 AntigenIBA 01/2024
1	tremelimumabIBA 01/2024
1	Monoclonal AntibodiesIBA 10/2023
1	Chemokine CXCL10IBA 10/2023
1	Keratin-17 (Keratin 17)IBA 10/2023
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023
1	atezolizumabIBA 01/2023
1	Nicotine FDA Link 01/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2023

Therapy/Procedure

18	Therapeutics 02/2024 - 06/2009
13	Drug Therapy (Chemotherapy) 10/2021 - 04/2008
8	Radiotherapy 01/2023 - 02/2005
5	Immunotherapy 01/2023 - 12/2018
5	Chemoradiotherapy 01/2022 - 12/2010
2	Organ Sparing Treatments 01/2024 - 11/2023
2	Castration 11/2021 - 09/2021
2	Patient Readmission 01/2021 - 12/2014
2	Prostatectomy (Retropubic Prostatectomy) 11/2016 - 08/2002
1	Liver Transplantation 02/2024
1	Cystectomy 11/2023
1	Precision Medicine 07/2023
1	Vascular Surgical Procedures 01/2023
1	Surgical Amputation (Amputations) 01/2023
1	Orthopedic Procedures 01/2023
1	Nicotine Replacement Therapy 01/2023